EUCTR2005-004984-43-IT进行中（未招募）不适用
Randomized, double-blind, placebo controlled trial on the efficacy of montelukast in exercise-induced asthma in children - MONTEIA
IVERSITA DEGLI STUDI DI UDINE0 个研究点目标入组 22 人开始时间: 2006年1月9日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •outpatients aged 6 to 14 years with a history of typical symptoms of exercise-induced asthma. pre-exercise FEV1 at least 75 of the predicted value 15 or greater decrease in FEV1 after a standardized treadmill exercise challenge Absence of farmacological treatment
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Sensitivity to montelukast Singulair or its components. a pulmonary disease other than asthma or other cronic pathologies acute upper respiratory tract infection
研究者
相似试验
进行中（未招募）
不适用
Study to assess the effectiveness of high doses of immunoglobulin in the treatment of polyneuropathy painful diabetic resistant to conventional therapiespainful diabetic polyneuropathy resistant to conventional therapiesMedDRA version: 14.1Level: SOCClassification code 10029205Term: Nervous system disordersSystem Organ Class: 10029205 - Nervous system disordersEUCTR2010-023883-42-ITAZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA' GRANDA (A.O. DI RILIEVO NAZIONALE)
进行中（未招募）
1 期
Randomized, double-blind, placebo-controlled trial to determine the capacity of VAK694 to elicit long term immune tolerance when combined with subcutaneous allergen immunotherapy for the treatment of seasonal allergic rhinitisEUCTR2009-013429-40-GBovartis Pharma Services AG
进行中（未招募）
1 期
Study of RV521 for the treatment of adults who have received a blood cell transplant and that have a respiratory infection caused by the virus RSVEUCTR2019-003746-33-FRReViral Ltd.200
招募中
3 期
Efficacy of Aripiprazole adjunctive treatment on body weight, metabolic parameters, clinical efficacy, and adverse events in people with psychotic disorders on treatment with Clozapine â?? A randomized, double-blind, placebo-controlled trialSchizoaffective disorderAntipsychotic induced weight gainMetabolic syndromeCTRI/2013/02/003397Christian Medical College60
进行中（未招募）
1 期
Randomized, double-blind, placebo-controlled trial to compare the effect, three months of follow-on pulse pressure and vascular function of isosorbide mononitrate extended release, associated with antihypertensive treatment in patients over 65 years refractory isolated systolic hypertension.Refractory isolated systolic hypertensionEUCTR2012-002988-10-ESFundación para la investigacion Biomedica